

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | nuclear pore complex assembly (GO:0051292) | 4.30883225 |
| 2 | establishment of protein localization to Golgi (GO:0072600) | 4.26413009 |
| 3 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.02948639 |
| 4 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 3.78398129 |
| 5 | protein targeting to Golgi (GO:0000042) | 3.72654338 |
| 6 | nuclear pore organization (GO:0006999) | 3.66305162 |
| 7 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.55912237 |
| 8 | interkinetic nuclear migration (GO:0022027) | 3.39586913 |
| 9 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.23006975 |
| 10 | pore complex assembly (GO:0046931) | 3.20037878 |
| 11 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.09543754 |
| 12 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.09314377 |
| 13 | negative regulation of vascular permeability (GO:0043116) | 3.05578583 |
| 14 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.04142269 |
| 15 | negative regulation of neurotransmitter secretion (GO:0046929) | 3.04061804 |
| 16 | negative regulation of protein localization to cell surface (GO:2000009) | 3.00168294 |
| 17 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.93096564 |
| 18 | regulation of cell communication by electrical coupling (GO:0010649) | 2.92985480 |
| 19 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.91116427 |
| 20 | negative regulation of neurotransmitter transport (GO:0051589) | 2.91114536 |
| 21 | glutamate secretion (GO:0014047) | 2.84533501 |
| 22 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.82364575 |
| 23 | regulation of sarcomere organization (GO:0060297) | 2.82019669 |
| 24 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 2.80084275 |
| 25 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.79721230 |
| 26 | L-amino acid import (GO:0043092) | 2.77534675 |
| 27 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 2.76510551 |
| 28 | nucleus localization (GO:0051647) | 2.76375766 |
| 29 | protein K48-linked deubiquitination (GO:0071108) | 2.73976176 |
| 30 | microtubule depolymerization (GO:0007019) | 2.67249800 |
| 31 | Golgi to endosome transport (GO:0006895) | 2.67103569 |
| 32 | microtubule polymerization or depolymerization (GO:0031109) | 2.66473684 |
| 33 | regulation of pigment cell differentiation (GO:0050932) | 2.63065995 |
| 34 | vesicle transport along microtubule (GO:0047496) | 2.62807412 |
| 35 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.61975415 |
| 36 | microtubule anchoring (GO:0034453) | 2.61223429 |
| 37 | regulation of synaptic vesicle transport (GO:1902803) | 2.60174847 |
| 38 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.58252789 |
| 39 | protein localization to Golgi apparatus (GO:0034067) | 2.55960081 |
| 40 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.55495811 |
| 41 | positive regulation of muscle hypertrophy (GO:0014742) | 2.53975257 |
| 42 | positive regulation of cardiac muscle hypertrophy (GO:0010613) | 2.53975257 |
| 43 | synaptic vesicle maturation (GO:0016188) | 2.50015818 |
| 44 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.49810893 |
| 45 | artery development (GO:0060840) | 2.48775187 |
| 46 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.48094092 |
| 47 | cell communication involved in cardiac conduction (GO:0086065) | 2.46966274 |
| 48 | C4-dicarboxylate transport (GO:0015740) | 2.46746554 |
| 49 | synaptic vesicle exocytosis (GO:0016079) | 2.45976243 |
| 50 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:0042787) | 2.44064399 |
| 51 | ventricular cardiac muscle cell action potential (GO:0086005) | 2.42889891 |
| 52 | musculoskeletal movement (GO:0050881) | 2.42769829 |
| 53 | multicellular organismal movement (GO:0050879) | 2.42769829 |
| 54 | regulation of female receptivity (GO:0045924) | 2.41181274 |
| 55 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.41121372 |
| 56 | organelle transport along microtubule (GO:0072384) | 2.38376651 |
| 57 | cyclic nucleotide catabolic process (GO:0009214) | 2.38117839 |
| 58 | neuronal action potential propagation (GO:0019227) | 2.37978915 |
| 59 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.37950500 |
| 60 | cardiac muscle cell action potential (GO:0086001) | 2.37525883 |
| 61 | long-chain fatty acid biosynthetic process (GO:0042759) | 2.37137987 |
| 62 | detection of calcium ion (GO:0005513) | 2.37077738 |
| 63 | membrane depolarization during action potential (GO:0086010) | 2.36447499 |
| 64 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 2.34795861 |
| 65 | cardiac muscle hypertrophy (GO:0003300) | 2.33564152 |
| 66 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 2.31132331 |
| 67 | regulation of translation, ncRNA-mediated (GO:0045974) | 2.31132331 |
| 68 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 2.31132331 |
| 69 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.29929544 |
| 70 | genitalia morphogenesis (GO:0035112) | 2.29567269 |
| 71 | clathrin coat assembly (GO:0048268) | 2.29431525 |
| 72 | regulation of establishment of cell polarity (GO:2000114) | 2.29400220 |
| 73 | intra-Golgi vesicle-mediated transport (GO:0006891) | 2.27476887 |
| 74 | calcium ion-dependent exocytosis (GO:0017156) | 2.27238226 |
| 75 | microtubule nucleation (GO:0007020) | 2.26958132 |
| 76 | carnitine shuttle (GO:0006853) | 2.26646893 |
| 77 | Golgi to plasma membrane protein transport (GO:0043001) | 2.26261590 |
| 78 | centrosome duplication (GO:0051298) | 2.25615854 |
| 79 | early endosome to late endosome transport (GO:0045022) | 2.25568115 |
| 80 | vesicle docking (GO:0048278) | 2.25522055 |
| 81 | gamma-aminobutyric acid transport (GO:0015812) | 2.25231303 |
| 82 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.24960115 |
| 83 | negative regulation of blood circulation (GO:1903523) | 2.24749655 |
| 84 | positive regulation of glycolytic process (GO:0045821) | 2.24504527 |
| 85 | cAMP catabolic process (GO:0006198) | 2.23144437 |
| 86 | regulation of low-density lipoprotein particle receptor biosynthetic process (GO:0045714) | 2.22573970 |
| 87 | striated muscle hypertrophy (GO:0014897) | 2.22364124 |
| 88 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.22135209 |
| 89 | serotonin metabolic process (GO:0042428) | 2.21935054 |
| 90 | amino acid import (GO:0043090) | 2.21654768 |
| 91 | Golgi to plasma membrane transport (GO:0006893) | 2.21313518 |
| 92 | myelination in peripheral nervous system (GO:0022011) | 2.20803936 |
| 93 | peripheral nervous system axon ensheathment (GO:0032292) | 2.20803936 |
| 94 | atrial cardiac muscle cell action potential (GO:0086014) | 2.20307889 |
| 95 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 2.19620561 |
| 96 | pre-miRNA processing (GO:0031054) | 2.19102356 |
| 97 | fibroblast migration (GO:0010761) | 2.18592359 |
| 98 | cGMP-mediated signaling (GO:0019934) | 2.15681531 |
| 99 | neuron-neuron synaptic transmission (GO:0007270) | 2.15327788 |
| 100 | synaptic vesicle endocytosis (GO:0048488) | 2.14061220 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 6.38130127 |
| 2 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.45272617 |
| 3 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.21132829 |
| 4 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.71775867 |
| 5 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.70659188 |
| 6 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.67729181 |
| 7 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 2.51142657 |
| 8 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.50845367 |
| 9 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.43138369 |
| 10 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.42622283 |
| 11 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 2.42234193 |
| 12 | SMAD4_21799915_ChIP-Seq_A2780_Human | 2.19642440 |
| 13 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.14329390 |
| 14 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.13613212 |
| 15 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 2.09980082 |
| 16 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.08584435 |
| 17 | STAT3_23295773_ChIP-Seq_U87_Human | 1.94839084 |
| 18 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.87710999 |
| 19 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.87597893 |
| 20 | P300_19829295_ChIP-Seq_ESCs_Human | 1.86688362 |
| 21 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.85628421 |
| 22 | FUS_26573619_Chip-Seq_HEK293_Human | 1.81466589 |
| 23 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.74234849 |
| 24 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.70418089 |
| 25 | TCF4_23295773_ChIP-Seq_U87_Human | 1.69109835 |
| 26 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.68928017 |
| 27 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.67804647 |
| 28 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.64591775 |
| 29 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.64006386 |
| 30 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.56955186 |
| 31 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.50485182 |
| 32 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.49831344 |
| 33 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.48359782 |
| 34 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.46889259 |
| 35 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.46033912 |
| 36 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.46022598 |
| 37 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.43434073 |
| 38 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.43102231 |
| 39 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.41800636 |
| 40 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.41697407 |
| 41 | AR_25329375_ChIP-Seq_VCAP_Human | 1.40733377 |
| 42 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.39419345 |
| 43 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.39419345 |
| 44 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.37205148 |
| 45 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.35805112 |
| 46 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.34711492 |
| 47 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.33310389 |
| 48 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.32853438 |
| 49 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.31690144 |
| 50 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.28741692 |
| 51 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.28230936 |
| 52 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.28223382 |
| 53 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.28223382 |
| 54 | VDR_22108803_ChIP-Seq_LS180_Human | 1.27010893 |
| 55 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.23243752 |
| 56 | EWS_26573619_Chip-Seq_HEK293_Human | 1.21646920 |
| 57 | TP53_16413492_ChIP-PET_HCT116_Human | 1.21586978 |
| 58 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.21517420 |
| 59 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.20580639 |
| 60 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.18823094 |
| 61 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.16877572 |
| 62 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.16877572 |
| 63 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.16329677 |
| 64 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.15713448 |
| 65 | AR_19668381_ChIP-Seq_PC3_Human | 1.14932430 |
| 66 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.14585289 |
| 67 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.13256983 |
| 68 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.11206500 |
| 69 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.10063456 |
| 70 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.10050780 |
| 71 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.09518463 |
| 72 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.08982828 |
| 73 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.08321520 |
| 74 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.07986736 |
| 75 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.07791131 |
| 76 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.06939418 |
| 77 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.06388222 |
| 78 | SOX9_26525672_Chip-Seq_HEART_Mouse | 1.05474073 |
| 79 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.05155268 |
| 80 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.04669804 |
| 81 | TBL1_22424771_ChIP-Seq_293T_Human | 1.04151252 |
| 82 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.03882402 |
| 83 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.03489788 |
| 84 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.03271355 |
| 85 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.01450561 |
| 86 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.00565479 |
| 87 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.00154301 |
| 88 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.99893303 |
| 89 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.99647071 |
| 90 | KDM2B_26808549_Chip-Seq_REH_Human | 0.99618097 |
| 91 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.99106517 |
| 92 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.98848908 |
| 93 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.97171040 |
| 94 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.94748100 |
| 95 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.93699436 |
| 96 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.93129666 |
| 97 | JUN_21703547_ChIP-Seq_K562_Human | 0.92777269 |
| 98 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.92490266 |
| 99 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.92396816 |
| 100 | REST_21632747_ChIP-Seq_MESCs_Mouse | 0.91459105 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004270_analgesia | 3.00070065 |
| 2 | MP0000569_abnormal_digit_pigmentation | 2.82336545 |
| 3 | MP0004859_abnormal_synaptic_plasticity | 2.71304763 |
| 4 | MP0009046_muscle_twitch | 2.60699227 |
| 5 | MP0002009_preneoplasia | 2.58650600 |
| 6 | MP0008057_abnormal_DNA_replication | 2.50218926 |
| 7 | MP0003646_muscle_fatigue | 2.26361728 |
| 8 | MP0009780_abnormal_chondrocyte_physiolo | 2.22171604 |
| 9 | MP0010352_gastrointestinal_tract_polyps | 2.19037748 |
| 10 | MP0009697_abnormal_copulation | 2.12697397 |
| 11 | MP0004036_abnormal_muscle_relaxation | 2.09497186 |
| 12 | MP0003880_abnormal_central_pattern | 2.04174883 |
| 13 | MP0004084_abnormal_cardiac_muscle | 2.04156722 |
| 14 | MP0004130_abnormal_muscle_cell | 2.03380210 |
| 15 | MP0001486_abnormal_startle_reflex | 1.97518599 |
| 16 | MP0005670_abnormal_white_adipose | 1.88523901 |
| 17 | MP0003635_abnormal_synaptic_transmissio | 1.81477278 |
| 18 | MP0004215_abnormal_myocardial_fiber | 1.76524390 |
| 19 | MP0001984_abnormal_olfaction | 1.75407362 |
| 20 | MP0003879_abnormal_hair_cell | 1.73066051 |
| 21 | MP0006276_abnormal_autonomic_nervous | 1.71186067 |
| 22 | MP0003941_abnormal_skin_development | 1.70569056 |
| 23 | MP0002064_seizures | 1.65829169 |
| 24 | MP0002272_abnormal_nervous_system | 1.62773020 |
| 25 | MP0003890_abnormal_embryonic-extraembry | 1.57760807 |
| 26 | MP0002063_abnormal_learning/memory/cond | 1.56348146 |
| 27 | MP0008004_abnormal_stomach_pH | 1.55831966 |
| 28 | MP0005409_darkened_coat_color | 1.54414983 |
| 29 | MP0005646_abnormal_pituitary_gland | 1.53583223 |
| 30 | MP0001501_abnormal_sleep_pattern | 1.48820230 |
| 31 | MP0004145_abnormal_muscle_electrophysio | 1.48641152 |
| 32 | MP0005187_abnormal_penis_morphology | 1.46727474 |
| 33 | MP0009745_abnormal_behavioral_response | 1.41815850 |
| 34 | MP0004233_abnormal_muscle_weight | 1.41153158 |
| 35 | MP0001879_abnormal_lymphatic_vessel | 1.40761804 |
| 36 | MP0005167_abnormal_blood-brain_barrier | 1.38079013 |
| 37 | MP0004484_altered_response_of | 1.36726630 |
| 38 | MP0002572_abnormal_emotion/affect_behav | 1.34743079 |
| 39 | MP0004085_abnormal_heartbeat | 1.33205815 |
| 40 | MP0004924_abnormal_behavior | 1.30660159 |
| 41 | MP0005386_behavior/neurological_phenoty | 1.30660159 |
| 42 | MP0005423_abnormal_somatic_nervous | 1.30110848 |
| 43 | MP0001661_extended_life_span | 1.28599251 |
| 44 | MP0004134_abnormal_chest_morphology | 1.26004530 |
| 45 | MP0002734_abnormal_mechanical_nocicepti | 1.22301560 |
| 46 | MP0001299_abnormal_eye_distance/ | 1.21735498 |
| 47 | MP0002638_abnormal_pupillary_reflex | 1.20761612 |
| 48 | MP0002557_abnormal_social/conspecific_i | 1.17666291 |
| 49 | MP0001188_hyperpigmentation | 1.17326690 |
| 50 | MP0004147_increased_porphyrin_level | 1.15551171 |
| 51 | MP0005410_abnormal_fertilization | 1.13637663 |
| 52 | MP0003633_abnormal_nervous_system | 1.10427352 |
| 53 | MP0002067_abnormal_sensory_capabilities | 1.09041126 |
| 54 | MP0002822_catalepsy | 1.08267635 |
| 55 | MP0008569_lethality_at_weaning | 1.06248862 |
| 56 | MP0000383_abnormal_hair_follicle | 1.05780560 |
| 57 | MP0006138_congestive_heart_failure | 1.05764638 |
| 58 | MP0005645_abnormal_hypothalamus_physiol | 1.05423951 |
| 59 | MP0002735_abnormal_chemical_nociception | 1.04171761 |
| 60 | MP0010386_abnormal_urinary_bladder | 1.01652936 |
| 61 | MP0005620_abnormal_muscle_contractility | 0.99971833 |
| 62 | MP0005551_abnormal_eye_electrophysiolog | 0.99896655 |
| 63 | MP0003787_abnormal_imprinting | 0.98277125 |
| 64 | MP0005666_abnormal_adipose_tissue | 0.98066136 |
| 65 | MP0003868_abnormal_feces_composition | 0.96800881 |
| 66 | MP0003137_abnormal_impulse_conducting | 0.95106637 |
| 67 | MP0000465_gastrointestinal_hemorrhage | 0.93990274 |
| 68 | MP0004811_abnormal_neuron_physiology | 0.91136146 |
| 69 | MP0005253_abnormal_eye_physiology | 0.91038878 |
| 70 | MP0005083_abnormal_biliary_tract | 0.90611793 |
| 71 | MP0000751_myopathy | 0.90011284 |
| 72 | MP0000778_abnormal_nervous_system | 0.88343546 |
| 73 | MP0003631_nervous_system_phenotype | 0.87745710 |
| 74 | MP0010678_abnormal_skin_adnexa | 0.87659096 |
| 75 | MP0000230_abnormal_systemic_arterial | 0.85936907 |
| 76 | MP0001968_abnormal_touch/_nociception | 0.85812904 |
| 77 | MP0000013_abnormal_adipose_tissue | 0.85636393 |
| 78 | MP0008877_abnormal_DNA_methylation | 0.84697279 |
| 79 | MP0002332_abnormal_exercise_endurance | 0.84234391 |
| 80 | MP0000631_abnormal_neuroendocrine_gland | 0.83748020 |
| 81 | MP0010329_abnormal_lipoprotein_level | 0.82410634 |
| 82 | MP0004043_abnormal_pH_regulation | 0.81876434 |
| 83 | MP0002876_abnormal_thyroid_physiology | 0.79972130 |
| 84 | MP0002733_abnormal_thermal_nociception | 0.79871911 |
| 85 | MP0002972_abnormal_cardiac_muscle | 0.78391702 |
| 86 | MP0009115_abnormal_fat_cell | 0.78271171 |
| 87 | MP0000427_abnormal_hair_cycle | 0.78269531 |
| 88 | MP0002106_abnormal_muscle_physiology | 0.78171117 |
| 89 | MP0008775_abnormal_heart_ventricle | 0.76680071 |
| 90 | MP0002971_abnormal_brown_adipose | 0.76184758 |
| 91 | MP0003698_abnormal_male_reproductive | 0.76093241 |
| 92 | MP0002882_abnormal_neuron_morphology | 0.75978416 |
| 93 | MP0001502_abnormal_circadian_rhythm | 0.75305072 |
| 94 | MP0000955_abnormal_spinal_cord | 0.74095278 |
| 95 | MP0001485_abnormal_pinna_reflex | 0.73762824 |
| 96 | MP0000647_abnormal_sebaceous_gland | 0.72229794 |
| 97 | MP0002234_abnormal_pharynx_morphology | 0.72177844 |
| 98 | MP0002184_abnormal_innervation | 0.70583519 |
| 99 | MP0002066_abnormal_motor_capabilities/c | 0.69909638 |
| 100 | MP0008961_abnormal_basal_metabolism | 0.69364396 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Papillary thyroid carcinoma (HP:0002895) | 4.19237171 |
| 2 | Febrile seizures (HP:0002373) | 3.51102940 |
| 3 | Progressive cerebellar ataxia (HP:0002073) | 3.11500709 |
| 4 | Tubulointerstitial nephritis (HP:0001970) | 3.10766159 |
| 5 | Genetic anticipation (HP:0003743) | 3.08527760 |
| 6 | Atonic seizures (HP:0010819) | 3.00521842 |
| 7 | Hyperventilation (HP:0002883) | 2.90195241 |
| 8 | Hyperkalemia (HP:0002153) | 2.86474726 |
| 9 | Drooling (HP:0002307) | 2.85588199 |
| 10 | Chronic hepatic failure (HP:0100626) | 2.75406771 |
| 11 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.73618110 |
| 12 | Gaze-evoked nystagmus (HP:0000640) | 2.72609947 |
| 13 | Truncal obesity (HP:0001956) | 2.71762660 |
| 14 | Urinary urgency (HP:0000012) | 2.62892616 |
| 15 | Hepatoblastoma (HP:0002884) | 2.60113939 |
| 16 | Termporal pattern (HP:0011008) | 2.59685511 |
| 17 | Insidious onset (HP:0003587) | 2.59685511 |
| 18 | Acanthocytosis (HP:0001927) | 2.55235360 |
| 19 | Excessive salivation (HP:0003781) | 2.50461558 |
| 20 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.47496497 |
| 21 | Thyroid carcinoma (HP:0002890) | 2.47305340 |
| 22 | Abnormality of the astrocytes (HP:0100707) | 2.45678391 |
| 23 | Astrocytoma (HP:0009592) | 2.45678391 |
| 24 | Dysmetric saccades (HP:0000641) | 2.45064073 |
| 25 | Broad-based gait (HP:0002136) | 2.41024581 |
| 26 | Epileptiform EEG discharges (HP:0011182) | 2.35567957 |
| 27 | Fair hair (HP:0002286) | 2.33962567 |
| 28 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.32654805 |
| 29 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.32654805 |
| 30 | Bundle branch block (HP:0011710) | 2.31712598 |
| 31 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.30110312 |
| 32 | Focal seizures (HP:0007359) | 2.25843675 |
| 33 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.22778825 |
| 34 | EEG with generalized epileptiform discharges (HP:0011198) | 2.22772773 |
| 35 | Sudden death (HP:0001699) | 2.22586306 |
| 36 | Right ventricular cardiomyopathy (HP:0011663) | 2.21616770 |
| 37 | Focal motor seizures (HP:0011153) | 2.19468534 |
| 38 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.17552501 |
| 39 | Subaortic stenosis (HP:0001682) | 2.17552501 |
| 40 | Medulloblastoma (HP:0002885) | 2.17372226 |
| 41 | Hypsarrhythmia (HP:0002521) | 2.16458711 |
| 42 | Abnormality of the ischium (HP:0003174) | 2.13803813 |
| 43 | Hypoplastic labia majora (HP:0000059) | 2.12631880 |
| 44 | Blue irides (HP:0000635) | 2.09405170 |
| 45 | Myokymia (HP:0002411) | 2.07439982 |
| 46 | Abnormality of the corticospinal tract (HP:0002492) | 2.06970181 |
| 47 | Overgrowth (HP:0001548) | 2.06770746 |
| 48 | Abnormality of the labia majora (HP:0012881) | 2.04499324 |
| 49 | Spastic gait (HP:0002064) | 2.02449269 |
| 50 | Absence seizures (HP:0002121) | 2.02143621 |
| 51 | Abnormal social behavior (HP:0012433) | 2.02125859 |
| 52 | Impaired social interactions (HP:0000735) | 2.02125859 |
| 53 | Dialeptic seizures (HP:0011146) | 1.99654026 |
| 54 | Syncope (HP:0001279) | 1.98923692 |
| 55 | Biliary tract neoplasm (HP:0100574) | 1.97105170 |
| 56 | Action tremor (HP:0002345) | 1.97056262 |
| 57 | Neoplasm of the heart (HP:0100544) | 1.97036859 |
| 58 | Generalized hypopigmentation of hair (HP:0011358) | 1.96477473 |
| 59 | Poor eye contact (HP:0000817) | 1.96184749 |
| 60 | Epileptic encephalopathy (HP:0200134) | 1.95487286 |
| 61 | Abnormal auditory evoked potentials (HP:0006958) | 1.93058644 |
| 62 | Poor coordination (HP:0002370) | 1.92806472 |
| 63 | Glioma (HP:0009733) | 1.92553117 |
| 64 | Nemaline bodies (HP:0003798) | 1.89649429 |
| 65 | Protruding tongue (HP:0010808) | 1.88776859 |
| 66 | Abnormality of potassium homeostasis (HP:0011042) | 1.88286924 |
| 67 | Renal cortical cysts (HP:0000803) | 1.87698995 |
| 68 | Impaired vibratory sensation (HP:0002495) | 1.87633578 |
| 69 | Decreased circulating renin level (HP:0003351) | 1.86736682 |
| 70 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 1.85081562 |
| 71 | Thyroid-stimulating hormone excess (HP:0002925) | 1.84756100 |
| 72 | Abnormality of secondary sexual hair (HP:0009888) | 1.83886618 |
| 73 | Abnormality of the axillary hair (HP:0100134) | 1.83886618 |
| 74 | Hyporeflexia of lower limbs (HP:0002600) | 1.83487017 |
| 75 | Absent eyebrow (HP:0002223) | 1.83247265 |
| 76 | Neoplasm of striated muscle (HP:0009728) | 1.82930104 |
| 77 | Genital tract atresia (HP:0001827) | 1.82901529 |
| 78 | Abnormality of the fingertips (HP:0001211) | 1.82372706 |
| 79 | Lower limb muscle weakness (HP:0007340) | 1.82088394 |
| 80 | Rhabdomyosarcoma (HP:0002859) | 1.80730605 |
| 81 | Muscle fiber inclusion bodies (HP:0100299) | 1.80361829 |
| 82 | Absent eyelashes (HP:0000561) | 1.79768453 |
| 83 | Postural instability (HP:0002172) | 1.78271352 |
| 84 | Volvulus (HP:0002580) | 1.78056623 |
| 85 | Acute myeloid leukemia (HP:0004808) | 1.77370602 |
| 86 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.77133716 |
| 87 | Papilledema (HP:0001085) | 1.76866128 |
| 88 | Vaginal atresia (HP:0000148) | 1.76030254 |
| 89 | Decreased lacrimation (HP:0000633) | 1.74181910 |
| 90 | Abnormality of the renal cortex (HP:0011035) | 1.72086243 |
| 91 | Short chin (HP:0000331) | 1.71450607 |
| 92 | Autoamputation (HP:0001218) | 1.71265936 |
| 93 | Short tibia (HP:0005736) | 1.70665062 |
| 94 | Calf muscle hypertrophy (HP:0008981) | 1.70056635 |
| 95 | Cystic hygroma (HP:0000476) | 1.69257750 |
| 96 | Decreased number of peripheral myelinated nerve fibers (HP:0003380) | 1.67267189 |
| 97 | Neoplasm of the small intestine (HP:0100833) | 1.66544109 |
| 98 | Failure to thrive in infancy (HP:0001531) | 1.66123316 |
| 99 | Hypoalphalipoproteinemia (HP:0003233) | 1.65823179 |
| 100 | Difficulty running (HP:0009046) | 1.65577921 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | AKT3 | 3.37824678 |
| 2 | MAP3K4 | 3.14292812 |
| 3 | CAMK1G | 2.67979307 |
| 4 | FRK | 2.55728649 |
| 5 | ZAK | 2.34260499 |
| 6 | CAMK1D | 2.30794582 |
| 7 | CASK | 2.20733006 |
| 8 | OBSCN | 2.16020509 |
| 9 | SGK2 | 2.09488012 |
| 10 | MAP2K7 | 1.98803707 |
| 11 | STK39 | 1.96293570 |
| 12 | TLK1 | 1.78296350 |
| 13 | EPHA3 | 1.72583701 |
| 14 | SGK494 | 1.67950391 |
| 15 | SGK223 | 1.67950391 |
| 16 | EPHA4 | 1.67049972 |
| 17 | BRD4 | 1.63070338 |
| 18 | NTRK3 | 1.61228947 |
| 19 | CSNK1A1L | 1.52293137 |
| 20 | MARK1 | 1.45282997 |
| 21 | FER | 1.41409230 |
| 22 | NLK | 1.40831765 |
| 23 | SGK3 | 1.38807072 |
| 24 | CDK12 | 1.37642579 |
| 25 | PIK3CG | 1.34106258 |
| 26 | CAMKK2 | 1.26684500 |
| 27 | ACVR1B | 1.24037425 |
| 28 | CAMK4 | 1.18707023 |
| 29 | CSNK1G1 | 1.17854686 |
| 30 | WNK1 | 1.17730459 |
| 31 | PLK2 | 1.14710052 |
| 32 | MAPK13 | 1.13511595 |
| 33 | MAP4K2 | 1.13292251 |
| 34 | CAMK1 | 1.10607612 |
| 35 | STK38 | 1.09258785 |
| 36 | PINK1 | 1.08193949 |
| 37 | PIK3CA | 1.07434474 |
| 38 | PLK4 | 1.07016077 |
| 39 | PRKAA2 | 1.05322209 |
| 40 | BMPR1B | 1.05048128 |
| 41 | LATS1 | 1.02022868 |
| 42 | PRKAA1 | 0.99467724 |
| 43 | MAP2K4 | 0.98070134 |
| 44 | MST4 | 0.96295470 |
| 45 | MET | 0.95659881 |
| 46 | SCYL2 | 0.93396341 |
| 47 | CSNK1G2 | 0.92925760 |
| 48 | BCR | 0.90825114 |
| 49 | MARK2 | 0.90505488 |
| 50 | CSNK1G3 | 0.90414894 |
| 51 | ERBB3 | 0.87581596 |
| 52 | PAK6 | 0.86276916 |
| 53 | PHKG1 | 0.86160585 |
| 54 | PHKG2 | 0.86160585 |
| 55 | STK38L | 0.86159361 |
| 56 | RPS6KA5 | 0.84082820 |
| 57 | SGK1 | 0.83748303 |
| 58 | TNIK | 0.83181683 |
| 59 | WNK3 | 0.83037426 |
| 60 | NEK6 | 0.82736216 |
| 61 | PAK3 | 0.81181881 |
| 62 | PKN1 | 0.79949102 |
| 63 | NTRK2 | 0.79283915 |
| 64 | OXSR1 | 0.75571156 |
| 65 | MAP3K2 | 0.74453778 |
| 66 | TAOK3 | 0.74261601 |
| 67 | MAP3K6 | 0.73250943 |
| 68 | INSRR | 0.72781903 |
| 69 | PRKCE | 0.70446992 |
| 70 | CDK5 | 0.67194544 |
| 71 | TEC | 0.65680548 |
| 72 | WNK4 | 0.65523266 |
| 73 | BRSK2 | 0.62288916 |
| 74 | RPS6KA3 | 0.60539906 |
| 75 | MYLK | 0.59546445 |
| 76 | CAMK2A | 0.57001438 |
| 77 | MST1R | 0.56449968 |
| 78 | MAPK10 | 0.55758373 |
| 79 | PRKD3 | 0.55636015 |
| 80 | TIE1 | 0.54738267 |
| 81 | DAPK2 | 0.53313958 |
| 82 | DMPK | 0.51973683 |
| 83 | PRKG1 | 0.50281917 |
| 84 | BMPR2 | 0.50137213 |
| 85 | MELK | 0.49640181 |
| 86 | DAPK3 | 0.48331479 |
| 87 | RET | 0.47029467 |
| 88 | CDK3 | 0.46519763 |
| 89 | MINK1 | 0.46175235 |
| 90 | CSNK1D | 0.45514387 |
| 91 | STK11 | 0.45428433 |
| 92 | CAMK2B | 0.45005511 |
| 93 | VRK1 | 0.44981345 |
| 94 | PDGFRB | 0.43852961 |
| 95 | ERBB2 | 0.43138478 |
| 96 | JAK1 | 0.42756830 |
| 97 | GSK3B | 0.41976208 |
| 98 | PRKCB | 0.41704196 |
| 99 | MAP3K7 | 0.41315360 |
| 100 | PRKACB | 0.40416405 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Alcoholism_Homo sapiens_hsa05034 | 3.27365826 |
| 2 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 3.05845637 |
| 3 | Nicotine addiction_Homo sapiens_hsa05033 | 2.79941444 |
| 4 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 2.20637193 |
| 5 | Circadian rhythm_Homo sapiens_hsa04710 | 2.11430409 |
| 6 | GABAergic synapse_Homo sapiens_hsa04727 | 1.91120798 |
| 7 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.86342131 |
| 8 | Morphine addiction_Homo sapiens_hsa05032 | 1.80461717 |
| 9 | Circadian entrainment_Homo sapiens_hsa04713 | 1.68415233 |
| 10 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.57171008 |
| 11 | Long-term potentiation_Homo sapiens_hsa04720 | 1.43178261 |
| 12 | Insulin secretion_Homo sapiens_hsa04911 | 1.42460505 |
| 13 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.40883395 |
| 14 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.40125245 |
| 15 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.38957252 |
| 16 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.35026539 |
| 17 | Taste transduction_Homo sapiens_hsa04742 | 1.33827927 |
| 18 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.33369931 |
| 19 | Olfactory transduction_Homo sapiens_hsa04740 | 1.32564968 |
| 20 | Adherens junction_Homo sapiens_hsa04520 | 1.30049703 |
| 21 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.27831884 |
| 22 | Renin secretion_Homo sapiens_hsa04924 | 1.24289459 |
| 23 | Salivary secretion_Homo sapiens_hsa04970 | 1.21450197 |
| 24 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.18640515 |
| 25 | Long-term depression_Homo sapiens_hsa04730 | 1.14872748 |
| 26 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.14447963 |
| 27 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.13916689 |
| 28 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.11712570 |
| 29 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.11118433 |
| 30 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.08999442 |
| 31 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.06019513 |
| 32 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.04167063 |
| 33 | Gap junction_Homo sapiens_hsa04540 | 1.03602046 |
| 34 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.02666324 |
| 35 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.00753574 |
| 36 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.00657213 |
| 37 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.97501641 |
| 38 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.95861190 |
| 39 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.95656110 |
| 40 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.95249166 |
| 41 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.95197482 |
| 42 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.93107415 |
| 43 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.90913849 |
| 44 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.89877577 |
| 45 | Cocaine addiction_Homo sapiens_hsa05030 | 0.88988690 |
| 46 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.87661474 |
| 47 | Tight junction_Homo sapiens_hsa04530 | 0.87636609 |
| 48 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.85393102 |
| 49 | Glioma_Homo sapiens_hsa05214 | 0.83906394 |
| 50 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.83852373 |
| 51 | Platelet activation_Homo sapiens_hsa04611 | 0.81812111 |
| 52 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.81777402 |
| 53 | Lysine degradation_Homo sapiens_hsa00310 | 0.81417739 |
| 54 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.81368990 |
| 55 | ABC transporters_Homo sapiens_hsa02010 | 0.80526271 |
| 56 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.77982962 |
| 57 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.76950800 |
| 58 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.76356196 |
| 59 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.75998011 |
| 60 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.75069702 |
| 61 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.73670393 |
| 62 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.73594057 |
| 63 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.71976164 |
| 64 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.71877770 |
| 65 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.71503687 |
| 66 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.71054929 |
| 67 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.69444198 |
| 68 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.69394391 |
| 69 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.68536979 |
| 70 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.68426308 |
| 71 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.68292854 |
| 72 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.67775240 |
| 73 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.67501579 |
| 74 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.64659061 |
| 75 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.64551478 |
| 76 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.63755814 |
| 77 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.63423840 |
| 78 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.63154525 |
| 79 | Bile secretion_Homo sapiens_hsa04976 | 0.61708762 |
| 80 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.61107296 |
| 81 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.59074725 |
| 82 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.58822474 |
| 83 | Thyroid cancer_Homo sapiens_hsa05216 | 0.58725667 |
| 84 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.58590732 |
| 85 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.58580971 |
| 86 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.56636690 |
| 87 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.56516238 |
| 88 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.55854940 |
| 89 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.54774536 |
| 90 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.54439809 |
| 91 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.53440855 |
| 92 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.52643156 |
| 93 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.52311373 |
| 94 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.50952843 |
| 95 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.50934731 |
| 96 | Insulin resistance_Homo sapiens_hsa04931 | 0.49713138 |
| 97 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.48670764 |
| 98 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.48150481 |
| 99 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.47728739 |
| 100 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.47066574 |

